61 – 70 of 122
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors
(
- Contribution to journal › Article
-
Mark
Management of carriers and babies with haemophilia
(
- Contribution to journal › Article
-
Mark
Venous access - why such diverse experiences of central venous lines?
2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.96-96(
- Contribution to journal › Published meeting abstract
-
Mark
Management of delivery and neonatal period
2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.5-5(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study
(
- Contribution to journal › Article
-
Mark
Prevention of bleeding in haemophilia: trends, overcoming barriers and future treatment options
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The thalassaemia syndromes
(
- Contribution to journal › Scientific review
-
Mark
Gadolinium Contrast Agent is of Limited Value for Magnetic Resonance Imaging Assessment of Synovial Hypertrophy in Hemophiliacs.
(
- Contribution to journal › Article
-
Mark
The risk associated with indwelling catheters in children with haemophilia.
(
- Contribution to journal › Scientific review
- 2006
-
Mark
Talassemi i Sverige – Behandlingsmål och uppföljning varierar kraftigt.
(
- Contribution to journal › Article